Jenny Shim, MD, is a Pediatric Hematologist and Oncologist at the Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta and Senior Associate in Pediatric Hematology/Oncology at Emory University School of Medicine. During the course of her career, Dr. Shim has focused her clinical and research career in pediatric solid tumors.
Dr. Shim’s current research interests center on improving our understanding of the genetics and tumor microenvironment of high-risk neuroblastoma, and identifying targetable therapeutic agents that will improve long-term survival. She is investigating the Yes-Associated Protein (YAP)/Hippo pathway in high-risk and recurrent neuroblastoma under the mentorship of Kelly Goldsmith, MD, a Pediatric Hematologist and Oncologist at Children’s. Dr. Shim will be delineating the YAP/Hippo pathway and its role in high-risk and recurrent neuroblastomas to develop a novel targeted therapy in combination with other potential targeted therapies, such as MEK or Bcl-2 inhibitors.
Dr. Shim hopes to continue working toward developing a strong clinical foundation in solid tumors, and building a career toward becoming a physician scientist with focus on basic and translational research. Alongside seeing patients in the clinical setting, she plans to become a physician scientist with her own funded laboratory focused on bringing bench-to-bedside novel therapies to improve long-term survival in patients with resistant pediatric solid tumors.
Focus of Practice
- Solid tumors
Areas of Interest
- Improving outcomes for high-risk and relapsed neuroblastoma
- Pediatric solid tumors
- Improving education for fellows, residents and medical students
Research & Publications
Dr. Shim’s research interests include the development of novel targeted therapies and immunotherapy in high-risk and relapsed neuroblastoma and pediatric solid tumors.